Results 221 to 230 of about 53,403 (325)

Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications

MedComm, Volume 7, Issue 2, February 2026.
The microbiome is related to the efficacy of immunotherapy and can be utilized to predict the efficacy and adverse reactions of immunotherapy. Microbiome‐targeted intervention strategies can improve the efficacy of ICI, but necessitating more comprehensive exploration.
Anqi Lin, Minying Xiong, Aimin Jiang, Li Chen, Lihaoyun Huang, Kailai Li, Hank Z. H. Wong, Jian Zhang, Zaoqu Liu, Quan Cheng, Bufu Tang, Pengpeng Zhang, Peng Luo   +12 more
wiley   +1 more source

Shoulder Pain Due to Humeral Metastasis: Unusual Presentation of Nasopharyngeal Carcinoma. [PDF]

Cureus
Dhake S, Naik R.
europepmc   +1 more source

Natural Products in Cancer Prevention and Therapy: Current Challenges and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Natural products play a pivotal role in cancer therapy. They induce cancer cell death by reprogramming four metabolic pathways while precisely targeting the tumor microenvironment and immune cells. These compounds not only leverage novel delivery systems for innovative applications but also demonstrate unique therapeutic efficacy across clinical stages:
Ruimiao Qian, Jun Ge, Ni Fan, Zheng Sun, Chengcheng Zhao, Yujiao Sun, Yingpeng Li, Yunfei Li, Hui Fu   +8 more
wiley   +1 more source

PRMT5 upregulates KCNMB4 expression via histone methylation to promote paclitaxel resistance in advanced nasopharyngeal carcinoma. [PDF]

Cell Death Dis
Liu L, Liu S, Wang Y, Wang P, Zhong G, Hong JH, Xiao R, Guo Y, Zhu F, Hao J, Chen J, Mai HQ, Tan J.   +12 more
europepmc   +1 more source

Auditory Preservation in Nasopharyngeal Carcinoma: Comparison of Proton and Photon Radiotherapy

Otolaryngology–Head and Neck Surgery, Volume 174, Issue 2, Page 450-457, February 2026.
Abstract Objective To compare cochlear dose and hearing outcomes between intensity‐modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) in patients with nasopharyngeal carcinoma (NPC). Study Design Prospective matched cohorts. Setting Tertiary academic center.
Kuang‐Hsu Lien, Chien‐Yu Lin, Po‐Yuan Chen, Joseph Tung‐Chieh Chang, Tai‐Yu Chen, Sheng‐Ping Hung, Ching‐Hsin Lee, Wing‐Keen Yap, Cheng‐En Hsieh, Cheng‐Lung Hsu, Chi‐Yin Lee, Kai‐Ping Chang   +11 more
wiley   +1 more source

Anlotinib monotherapy in recurrent or metastatic nasopharyngeal carcinoma: a multicenter case-series analysis. [PDF]

Radiol Oncol
Qin GJ, Su YX, Liang Y, Zhang B, Pan YF, Lu JX, Xie YY, Dai JX, Chen KQ, Qin FF, Yang HY, Kong XY, Xie Y, Ruan XL, Mo YY, Zhang RY, Zhang J, Jiang W.   +17 more
europepmc   +1 more source

Inflammatory pseudotumor of the liver misdiagnosed as a metastatic tumor of nasopharyngeal carcinoma: a typical case report of mistreatment caused by anchoring bias. [PDF]

Front Med (Lausanne)
Zhao Z, Wang J, Xiao Y, Cui M, Li J, Ma J.   +5 more
europepmc   +1 more source

Burden and Trends of Nasopharyngeal Cancer Among Younger People in the Western Pacific Region, 1990 to 2021: Findings from the 2021 Global Burden of Disease Study. [PDF]

J Otolaryngol Head Neck Surg
Zhou L, Ma G, Jia W, Zhang Y, Wu L, Ye Y, Liu D, Li X.   +7 more
europepmc   +1 more source

Analysis of the application of 3D-printed personalized positioning fixation in nasopharyngeal carcinoma radiotherapy. [PDF]

J Appl Clin Med Phys
Ding Z, Li GQ, Liu Q, Zhu X, Tan L, Kang J, Wang Y, Yang Z, Ren J, Han J, Cheng P.   +10 more
europepmc   +1 more source

Imaging-based transformer model predicts early therapy response in advanced nasopharyngeal carcinoma: a dual-center study. [PDF]

Insights Imaging
Shi K, Chen C, Fei Y, Qiu L, Yuan J, Zhu Y, Luo J, Xu W, Cao Y, Zhou S.   +9 more
europepmc   +1 more source